2097262-60-5 (FASN inhibitor 1,FASN inhibitor 1)

化合物FASN-IN-3;4-(1-(5-(3,4-二甲基-1H-吡唑-5-基0-2,4-二甲基苯甲酰基)氮杂环丁烷-3-基)苯甲腈;

FASN-IN-3;FASN inhibitor 1;Benzonitrile, 4-[1-[5-(3,4-dimethyl-1H-pyrazol-5-yl)-2,4-dimethylbenzoyl]-3-azetidinyl]-;4-(1-(5-(3,4-Dimethyl-1H-pyrazol-5-yl)-2,4-dimethylbenzoyl)azetidin-3-yl)benzonitrile;4-{1-[5-(4,5-Dimethyl-2H-pyrazol-3-yl)-2,4-dimethyl-benzoyl]-azetidin-3-yl}-benzonitrile;4-[1-[5-(4,5-dimethyl-1H-pyrazol-3-yl)-2,4-dimethylbenzoyl]azetidin-3-yl]benzonitrile;4-[1-[5-(4,5-Dimethyl-1H-pyrazol-3-yl)-2,4-dimethylbenzoyl]-3-azetidinyl]benzonitrile;US9428502, 242;SCHEMBL15559827;4-(1-(5-(4,5-Dimethyl-1H-pyrazol-3-yl)-2,4-dimethylbenzoyl)azetidin-3-yl)benzonitrile;4-{1-[5-(4,5-dimethyl-1H-pyrazol-3-yl)-2,4-dimethylbenzoyl]azetidin-3-yl}benzonitrile;BS-45242;GLXC-10018;DA-63382;DB-153395;EX-A4622;TVB-3166;CS-0035379;HY-U00436;CHEMBL3923704;BDBM244633;1533438-83-3;AKOS040733375;4-[1-[5-(4,5-dimethyl-1H-pyrazol-3-yl)-2,4-dimethylbenzoyl]-3-azetidinyl]-benzonitrile;2097262-60-5;TVB-3166?;E74928;TVB-3166, >=98% (HPLC);AKOS040742789;starbld0000754;

ICDQFUFDAFKCAX-UHFFFAOYSA-N

1S/C24H24N4O/c1-14-9-15(2)22(10-21(14)23-16(3)17(4)26-27-23)24(29)28-12-20(13-28)19-7-5-18(11-25)6-8-19/h5-10,20H,12-13H2,1-4H3,(H,26,27)

C(#N)C1=CC=C(C2CN(C(=O)C3=CC(C4NN=C(C)C=4C)=C(C)C=C3C)C2)C=C1